首页> 美国卫生研究院文献>Reproductive Biology and Endocrinology : RBE >Effect of different artificial shrinkage methods when applied before blastocyst vitrification on perinatal outcomes
【2h】

Effect of different artificial shrinkage methods when applied before blastocyst vitrification on perinatal outcomes

机译:在囊胚玻璃化之前应用不同的人工收缩方法对围产期结局的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn recent years, single blastocyst transfer combined with vitrification has been applied widely, which can maximize the cumulative pregnancy rate in per oocyte retrieval cycles and minimize the multiple pregnancy rate. Thus, the guarantee for these is the effectiveness of vitrified blastocyst. Studies has shown that AS of the blastocoel cavity prior to vitrification can reduce injuries, increase the thawed blastocyst survival rate and implantation rate. Several AS methods have been established. However, only a few studies have compared the effectiveness and safety of these AS methods. In this study, we aimed to compare the clinical outcomes and neonatal outcomes in FET cycles with single blastocyst that were artificially shrunk before vitrification by either LAS or MNAS method.
机译:背景技术近年来,单囊胚移植与玻璃化结合已得到广泛应用,这可以使每个卵母细胞回收周期中的累积妊娠率最大化,并使多重妊娠率最小化。因此,这些的保证是玻璃化胚泡的有效性。研究表明,玻璃化前囊胚腔的AS可以减少损伤,增加解冻的囊胚存活率和植入率。已经建立了几种AS方法。但是,只有少数研究比较了这些AS方法的有效性和安全性。在这项研究中,我们旨在比较LAS或MNAS方法在玻璃化之前人工缩小的单个胚泡的FET周期的临床结果和新生儿结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号